Chart of the Day - Genmark Diagnostics (GNMK)

The Chart of the Day is Genmark Diagnostics (GNMK).  I found the stock by sorting the New High List for frequency in the last month, skipped the stocks that didn't have a positive gain for the last week and month and used the Flipchart feature to review the charts,  Since the Trend Spotter signaled a buy on 12/20 the stock gained 11.92%.

It is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor' XT-8 system is the second generation in GenMark Dx's eSensor' platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots.

 Please share this article